Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Antiobesity Medications: Expert Compares Benefits, Drawback Among Classes
Obesity specialist Sandra Christensen, MSN, ARNP, compares the benefits and drawbacks among older antiobesity drugs and newer GLP-1RAs liraglutide and semaglutide 2.4 mg.
In a recent interview with Patient Care Online, medical weight management specialist Sandra Christensen, MSN, ARNP, was asked the following question:
What are the benefits and drawbacks to the different classes of antiobesity medications?
Ms Christensen discusses how the different classes of antiobesity medications compare in cost, side effect profiles, and more in the video below.
For a primer on common antiobesity medications, check out part 1 of our interview with Ms Christensen: Antiobesity Medications: Expert Discusses Older, Newer Therapies
Sandra Christensen, MSN, ARNP, is the owner of Integrative Medical Weight Management in Seattle, Washington.
Recent Videos
Related Content
